Researchers at the University of Cincinnati found that the blood-clot dissolving drug (tPA) can help reduce the number of patients left disabled after suffering from strokes, saving $200 million in annual disability costs. Strokes are the third leading cause of death in the U.S.
Read the full story
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.